Also trades as: MEDANTA.BO (BSE) · $vol 1M · GLH.AX (ASX) · $vol 0M

₹1,328.20 ($13.79)

-29.10 (-2.14%)

NSE · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 35 · ₹364.9B mcap · 88M float · 0.290% daily turnover

Revenue

$44.1B +21.3% ▲

5Y CAGR: +25.3%

Gross Profit

$20.9B -24.0% ▼

5Y CAGR: +14.2%

Operating Income

$7.0B -5.5% ▼

5Y CAGR: +49.7%

Net Income

$5.6B +15.6% ▲

5Y CAGR: +80.8%

EPS (Diluted)

$20.66 +15.3% ▲

5Y CAGR: +78.5%

EBITDA

$10.2B +12.3% ▲

5Y CAGR: +35.5%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$21.7B	$26.9B	$32.8B	$36.9B	$44.1B
YoY Growth	+51.6%	+24.3%	+21.6%	+12.7%	+21.3%
Cost of Revenue	$5.4B	$6.3B	$15.6B	$17.0B	$23.2B
Gross Profit	$16.2B	$20.7B	$17.2B	$19.9B	$20.9B
Gross Margin	74.9%	76.8%	52.4%	53.8%	47.5%
R&D Expenses	$590K	$340K	$420K	$4M	$0
SG&A Expenses	$3.0B	$4.2B	$5.4B	$5.0B	$14.0B
Operating Expenses	$4.8B	$6.6B	$5.4B	$5.0B	$14.0B
Operating Income	$3.3B	$4.9B	$11.7B	$14.9B	$7.0B
Operating Margin	15.3%	18.3%	35.8%	40.4%	15.8%
Interest Expense	$795M	$779M	$720M	$653M	$791M
Income Before Tax	$2.8B	$4.5B	$6.3B	$6.5B	$7.2B
Tax Expense	$844M	$1.2B	$1.5B	$1.7B	$1.6B
Net Income	$2.0B	$3.3B	$4.8B	$4.8B	$5.6B
Net Margin	9.1%	12.1%	14.6%	13.0%	12.6%
EPS (Diluted)	$7.77	$12.57	$17.80	$17.92	$20.66
EBITDA	$4.9B	$6.8B	$8.7B	$8.8B	$10.2B
Shares Outstanding	252M	259M	269M	269M	269M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$8.6B	$9.6B	$9.4B	$8.8B	$10.3B	$11.0B	$11.2B	$11.6B
Cost of Revenue	$4.6B	$2.3B	$2.3B	$2.1B	$2.4B	$2.6B	$2.6B	$6.0B
Gross Profit	$4.0B	$7.3B	$7.1B	$6.6B	$7.9B	$8.4B	$8.7B	$5.6B
Gross Margin	47.0%	76.2%	75.7%	75.6%	76.8%	76.8%	77.2%	48.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.2B	$1.3B	$1.2B	$2.6B	$1.4B	$1.5B	$1.8B	$3.8B
Operating Expenses	$2.6B	$5.4B	$5.2B	$4.5B	$6.1B	$6.6B	$7.1B	$3.8B
Operating Income	$1.4B	$1.8B	$1.9B	$2.1B	$1.8B	$1.8B	$1.6B	$1.8B
Operating Margin	16.8%	19.3%	20.4%	24.5%	17.6%	16.5%	13.9%	15.3%
Interest Expense	$180M	$160M	$163M	$150M	$138M	$171M	$215M	$267M
Income Before Tax	$1.4B	$1.8B	$1.9B	$1.3B	$2.1B	$2.0B	$1.2B	$1.9B
Tax Expense	$374M	$503M	$462M	$321M	$492M	$414M	$248M	$456M
Net Income	$1.1B	$1.3B	$1.4B	$1.0B	$1.6B	$1.6B	$950M	$1.4B
Net Margin	12.3%	13.7%	15.1%	11.6%	15.4%	14.4%	8.5%	12.4%
EPS (Diluted)	$3.96	$4.87	$5.32	$3.77	$5.91	$5.89	$3.54	$5.35
EBITDA	$2.1B	$2.5B	$2.5B	$2.0B	$2.7B	$2.7B	$2.0B	$2.8B
Shares Outstanding	268M	269M	269M	269M	269M	269M	268M	269M

MEDANTA.NS NSE